Abstract:Objective This study aimed to explore the efficacy of the esophageal bed pathway and the retrosternal pathway on thoracoscopic resection of esophageal cancer. Methods A total of 116 patients with esophageal cancer in Nanshi Hospital of Nanyang were included between January 2018 and January 2022 for a retrospective cohort study. Among the patients, 69 were male and 47 were female [aged 45-67 (56.5±5.5) years old], with 26, 67, and 23 having stage Ⅰ, Ⅱ, and Ⅲ esophageal cancer, respectively. All 116 patients underwent thoracoscopic resection of esophageal cancer, and they were divided into two groups according to different surgical pathways, including 58 patients with thoracoscopic resection of esophageal cancer via esophageal bed pathway (esophageal bed group) and 58 patients with thoracoscopic resection of esophageal cancer via the retrosternal pathway (retrosternal group). The observation indicators were as follows. (1) Baseline data such as gender, age, course of disease, tumor type, tumor location, and comorbidities were compared between the two groups. (2) Surgical time, intraoperative blood loss, postoperative indwelling time of drainage tube, total gastric fluid drainage volume, and occurrence of complications such as postoperative incision infection, pulmonary infection, chylothorax, anastomotic fistula, and arrhythmia were compared between the two groups. (3) Standardized swallowing assessment (SSA), Burke dysphagia screening scale (Burke score), and X-ray video-fluoroscopy swallowing study (VFSS) were used to evaluate and compare the swallowing function in the two groups before surgery and 3 months after. (4) The total score and scores of items of quality of life 3 months after were compared between the two groups. (5) The recurrence, metastasis, and survival of the two groups were compared during follow-up. Results (1) No statistically significant differences existed in baseline data between the two groups (all P values>0.05). (2) All 116 patients successfully completed the surgery, and no statistical differences existed in the surgical time and intraoperative blood loss (t=1.50,1.20,all P values >0.05). The total postoperative gastric fluid drainage volume with (349.7±41.9) mL in the retrosternal group was smaller than that (736.2±52.1) mL in the esophageal bed group. The incidence rate of anastomotic fistula with 13.8% (8/58) was higher than 1.7% (1/58) in the esophageal bed group, and the differences were statistically significant (t=44.03,χ2=4.34,all P values <0.05). There were no statistical differences existed in the postoperative drainage indwelling time and incidence rates of complications such as pulmonary infection, chylothorax, and arrhythmia between the two groups (all P values >0.05). (3) All 116 patients were followed up for 3-12 (7.3±1.5) months. The scores of swallowing function SSA, Burke, and VFSS 3 months after were (24.2±1.2), (2.5±0.3) points, and (7.2±0.9) points in the esophageal bed group, respectively. The corresponding scores in the retrosternal group were (24.5±1.2) points, (2.6±0.3) points, and (7.0±0.8) points, respectively. The SSA score and Burke score in the two groups 3 months after were lower than those before surgery, whereas the VFSS score was higher than that before surgery, and the differences were statistically significant (all P values <0.05). No statistically significant differences existed in the scores of SSA, Burke, and VFSS between the two groups before surgery and 3 months after (all P values >0.05). (4) No statistical differences existed in the total score and scores of items of quality of life between the two groups 3 months after (all P values >0.05). (5) Follow-up revealed 2 cases of recurrence and 1 of liver metastasis in the retrosternal group, and 1 case of recurrence, 1 of bone metastasis, and 1 of brain metastasis in the esophageal bed group. No statistically significant difference existed in the recurrence rate and metastasis rate between the two groups (χ2=0.51,0.00,all P values>0.05), and no death occurred in the two groups during follow-up. Conclusion Esophageal bed pathway and retrosternal pathway for thoracoscopic resection of esophageal cancer can achieve good tumor-treatment effects. Both can improve the swallowing function and enhance the quality of life of patients. Esophageal bed pathway has low incidence rate of anastomotic fistula, and retrosternal pathway has low total amount of gastric fluid drainage.
余德旺, 王东方, 靳红领, 王炎. 食管床路径与胸骨后路径胸腔镜食管癌切除术的疗效比较[J]. 中华解剖与临床杂志, 2023, 28(10): 672-678.
Yu Dewang, Wang Dongfang, Jin Hongling, Wang Yan. Comparison of efficacy of esophageal bed pathway and retrosternal pathway on thoracoscopic resection of esophageal cancer. Chinese Journal of Anatomy and Clinics, 2023, 28(10): 672-678.
丁倩,何爽,宁妍妍,等. 精细化营养支持对食管癌患者术后营养状况、恢复情况及生活质量的影响[J]. 癌症进展, 2022, 20(5): 513-516. DOI: 10.11877/j.issn.1672-1535.2022.20.05.22Ding Q, He S, Ning YY, et al.Effect of refined nutritional support on postoperative nutritional status, recovery and quality of life in patients with esophageal cancer[J]. Oncology Progress, 2022, 20(5): 513-516. DOI: 10.11877/j.issn. 1672-1535.2022.20.05.22
张国亮, 朱奇坤,翁晨刚, 等. 胸腔镜手术治疗食管癌合并气管憩室9例报告[J]. 中国微创外科杂志, 2022, 22(8): 675-678. DOI: 10.3969/j.issn.1009-6604.2022.08.013Zhang GL, Zhu QK, Weng CG, et al.Video-assisted thoracoscopic surgery for esophageal cancer coexistence with tracheal diverticulum: a clinical analysis of 9 cases[J]. Chinese Journal of Minimally Invasive Surgery, 2022, 22(8): 675-678. DOI: 10.3969/j.issn.1009-6604.2022.08.013
[5]
田界勇,梅新宇,张天赐,等. 胸骨后重建路径联合术后辅助放疗在微创Mckeown食管癌切除术近期并发症与安全性分析[J]. 中山大学学报(医学科学版), 2022, 43(4) :653-660. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2022.0417Tian JY, Mei XY, Zhang TC, et al.Short term complications and safety analysis of retrosternal reconstruction pathway combined with postoperative adjuvant radiotherapy in minimally invasive Mckeown esophagectomy[J]. Journal of Sun Yat-Sen University (Medical Sciences), 2022, 43(4) :653-660. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci). 2022.0417
[6]
石长林,张冉,何鸿晏,等. 管状胃-食管吻合术联合胸腔镜食管癌切除术在老年食管癌治疗中的应用[J]. 实用癌症杂志, 2020, 35(8): 1294-1297. DOI: 10.3969/j.issn.1001-5930.2020.08.020Shi CL, Zhang R, He HY, et al.Application of tubular gastroesophageal anastomosis combined with thoracoscopic esophageal cancer resection in elderly patients with esophageal cancer[J]. The Practical Journal of Cancer, 2020, 35(8): 1294-1297. DOI: 10.3969/j.issn.1001-59302020.08.020
张婧,王拥军,崔韬. 脑卒中后吞咽困难9个评价量表的信度及效度研究[J]. 中国临床康复,2004,8(7):1201-1203. DOI:10.3321/j.issn:1673-8225.2004.07.001Zhang J, Wang Yj, Cui T.Reliability and validity of nine rating scales for dysphagia following stroke[J]. Chin J Clin Rehabil, 004,8(7):1201-1203. DOI:10.3321/j.issn:1673-8225.2004.07.001
[9]
Edmiaston J, Connor LT, Steger-May K,et al.A simple bedside stroke dysphagia screen, validated against videofluoroscopy, detects dysphagia and aspiration with high sensitivity[J]. J Stroke Cerebrovasc Dis,2014,23(4):712-716. DOI: 10.1016/j.jstrokecerebrovasdis.2013.06.030
[10]
姜宝法,刘春晓,崔永春,等. EORTC QLQ-C30的信度、效度研究[J].中国临床心理学杂志,2005,13(1):31-32,36.DOI:10.3969/j.issn.1005-3611.2005.01.009Jiang BF, Liu CX, Cui YC, et al.Reliability and validity for Chinese version of QLQ-C30[J]. Chin J Clin Psychol, 2005,13(1):31-32,36.DOI:10.3969/j.issn.1005-3611.2005.01.009
[11]
钱勇,陈振东. 食管癌化疗患者生存质量测定量表中文版的研制与考评[J]. 中国肿瘤,2007,16(11):855-857. DOI:10.3969/j.issn.1004-0242.2007.11.002Qian Y, Chen ZD.Development and evaluation on quality of life questionnaire for esophageal cancer patients during chemotherapy,Chinese version[J]. Chin Cancer, 2007,16(11):855-857. DOI:10.3969/j.issn.1004-0242.2007.11.002
[12]
许若煊,李冬斌,张旭,等. 食管癌致病因素及对预后影响的研究进展[J]. 河北医药, 2022, 44(10): 1556-1560,1565. DOI: 10.3969/j.issn.1002-7386.2022.10.028Xu RX, Li DB, Zhang X, et al.Research progress on pathogenic factors and prognosis of esophageal cancer[J]. Hebei Medical Journal, 2022, 44(10): 1556-1560,1565. DOI: 10.3969/j.issn.1002-7386.2022.10.028
[13]
郑勇,闫颖伟,刘俊山. 全胸腹腔镜下食管癌根治食管胃颈部机械吻合术后患者生活质量分析[J]. 实用癌症杂志, 2021, 36(2): 275-279. DOI: 10.3969/j.issn.1001-5930.2021.02.025Zheng Y, Yan YW, Liu JS.Analysis of quality of life after total thoracic laparoscopic radical resection of esophageal and gastric cancer[J]. The Practical Journal of Cancer, 2021, 36(2): 275-279. DOI: 10.3969/j.issn.1001-5930.2021.02.025
[14]
张仑,蔡金凤,张华. 三维适形放疗联合化疗对中、晚期食管癌患者近期疗效、毒副反应及远期预后生存的影响[J]. 解放军医药杂志, 2021, 33(6): 25-29. DOI: 10.3969/j.issn.2095-140X.2021.06.005Zhang L, Cai JF, Zhang H.Effects of three-dimensional conformal radiotherapy combined with chemotherapy on short-term curative effect, toxic and side reaction and long-term prognosis of patients with moderate or advanced esophageal cancer[J]. Medical 00026; Pharmaceutical Journal of Chinese People's Liberation Army, 2021, 33(6): 25-29. DOI: 10.3969/j.issn.2095-140X.2021.06.005
[15]
中华人民共和国国家卫生健康委员会医政医管局. 食管癌诊疗指南(2022年版)[J]. 中华消化外科杂志,2022,21(10):1247-1268. DOI:10.3760/cma.j.cn115610-20220726-00433Bureau of Medical Administration, National Health Commission of the People's Republic of China. Standardization for diagnosis and treatment of esophageal cancer (2022 edition)[J]. Chin J Dig Surg, 2022,21(10):1247-1268. DOI:10.3760/cma.j.cn115610-20220726-00433
[16]
汪永和, 岳庆峰, 江陈, 等. 胸腹腔镜联合下食管癌切除术与开放手术的临床疗效对比[J].中国内镜杂志, 2022, 28(3): 23-28. DOI: 10.12235/E20210232Wang YH, Yue QF, Jiang C, et al.Comparison of clinical efficacy between thoracoscopic laparoscopy combined with esophagectomy and open surgery[J]. China Journal of Endoscopy,2022,28(3):23-28. DOI: 10.12235/E20210232
[17]
李伟, 李仁拴, 苗满园, 等. 3种术式治疗胸中段食管癌的近期疗效及安全性评价[J].广西医科大学学报,2017,34(2):222-226. DOI: 10.16190/j.cnki.45-1211/r.2017.02.015Li W, Li RS, Miao MY, et al.The short-term efficacy and security of three types of surgeries to treat middle thoracic esophageal carcinoma[J].Journal of Guangxi Medical University,2017,34(2):222-226. DOI: 10.16190/j.cnki.45-1211/r.2017.02.015
[18]
Achim V, Aye RW, Farivar AS, et al.A combined thoracoscopic and laparoscopic approach for high epiphrenic diverticula and the importance of complete myotomy[J]. Surg Endosc, 2017,31(2):788-794. DOI: 10.1007/s00464-016-5033-4
[19]
何静, 陈瑞, 何建明. 食管癌术后单食管床引流管与胸腔、纵隔双管引流的应用效果比较[J].实用临床医药杂志,2019,23(11):46-48. DOI: 10.7619/jcmp.201911013He J, Chen R, He JM.Single esophageal bed drainage tube versus thoracic and mediastinal double-tube drainage after esophageal cancer operation[J].Journal of Clinical Medicine in Practice,2019,23(11):46-48. DOI: 10.7619/jcmp.201911013
张晓彬,杨煜,孙益峰,等. 经胸骨后与后纵隔管状胃上提路径对食管癌术后并发症及近期生活质量影响的病例对照研究[J]. 中国胸心血管外科临床杂志, 2018, 25(2): 143-147. DOI: 10.7507/1007-4848.201701020Zhang XB, Yang Y, Sun YF, et al.Effect of retrosternal versus posterior mediastinum approach for tubular stomach reconstruction on early surgical complications and short-term quality of life in patients with McKeown esophagectomy: A case control study[J]. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2018, 25(2): 143-147. DOI: 10.7507/1007-4848.201701020
[22]
王兴邦,蒋鹏鹏,朱思宇. 管状胃经胸骨后路径与经食管床路径应用于胸腔镜联合食管癌手术对治疗成功率肺功能及术后并发症的影响[J]. 河北医学, 2021, 27(5): 757-762. DOI: 10.3969/j.issn.1006-6233.2021.05.012Wang XB, Jiang PP, Zhu SY.Effect of tube stomach retrosternal and transesophageal bed pathways on the success rate lung function and postoperative complications of thoracoscopic combined with esophageal cancer surgery[J]. Hebei Medicine, 2021, 27(5): 757-762. DOI: 10.3969/j.issn.1006-6233.2021.05.012
[23]
马生茂, 党继芳, 张华, 等. 不同手术入路对食管癌切除患者的淋巴结清扫及治疗效果影响[J].河北医学, 2019, 25(3): 664-667. DOI: 10.3969/j.issn.1006-6233.2019.03.035Ma SM, Dang JF, Zhang H, et al.Effect of different operative approaches on lymph node dissection and treatment of patients with esophageal carcinoma[J]. Hebei Medicine,2019,25(3):664-667. DOI: 10.3969/j.issn.1006-6233.2019.03.035
[24]
姜睿. 两种不同消化道重建路径对胸腔镜联合食管癌手术治疗的效果影响[J].实用医院临床杂志,2017,14(3):88-90. DOI: 10.3969/j.issn.1672-6170.2017.03.030Jiang R.The effect of two types of digestive tract reconstruction paths after esophageal cancer surgery combined with thoracoscope[J].Practical Journal of Clinical Medicine,2017,14(3):88-90. DOI: 10.3969/j.issn.1672-6170.2017.03.030
[25]
方文涛, 陈文虎, 范利民, 等. 食管癌切除术后不同重建途径吻合口瘘的原因及预防[J].中华胃肠外科杂志,2005,8(3):217-219. DOI: 10.3760/cma.j.issn.1671-0274.2005.03.008Fang WT, Chen WH, Fan LM, et al.Canses and prevention of anastomotic leakage after esophagectomy and reconstruction through different routes for esophageal cancer[J].Chin J Gastrointest Surg, 2005,8(3):217-219. DOI: 10.3760/cma.j.issn.1671-0274.2005.03.008
[26]
刘明, 党建中. 中西医结合治疗食管癌切除术后吻合口瘘疗效观察[J].西部中医药,2018,31(3):102-104. DOI: 10.3969/j.issn.1004-6852.2018.03.032Liu M, Dang JZ.Observation on clinical effects of integrative medicine in treating anastomotic leakage after the excision of esophageal cancer[J]. Western Journal of Traditional Chinese Medicine,2018,31(3):102-104. DOI: 10.3969/j.issn.1004-6852.2018.03.032.